Skip to main content

Closed

MCRB: Seres Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-7641.0%

ROIC-80.3%

Financially safe

Stretched

Debt / equity3.04×

Interest coverage0.0×

Current ratio1.65×

Seres Therapeutics, Inc.

MCRBNASDAQ Global Select·USD·Closed

Seres Therapeutics, Inc.

MCRBNASDAQ·USD·Closed

$4.83

+1.05%

$4.83

+$0.05 (1.05%)

52W Range

1thpctl

Volume

0.59×avg

Mkt Cap

46.77MUSD

P/E

-0.9TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.59×avg

Market Cap

46.77MUSD

P/E Ratio

-0.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings